MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 162 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,140 | – | 131 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,495,392 | $222,077,452 | 10.39% |
| BOONE CAPITAL MANAGEMENT LLC | 523,679 | $17,904,585 | 4.67% |
| TANG CAPITAL MANAGEMENT LLC | 1,287,107 | $44,006,188 | 4.48% |
| BVF INC/IL | 4,370,024 | $149,411,121 | 4.19% |
| First Turn Management, LLC | 703,398 | $24,049,178 | 3.91% |
| Nan Fung Group Holdings Ltd | 106,100 | $3,627,559 | 3.87% |
| Prosight Management, LP | 314,800 | $10,763,012 | 3.22% |
| Novo Holdings A/S | 1,500,000 | $51,285,000 | 2.98% |
| Lion Point Capital, LP | 45,000 | $1,538,550 | 2.80% |
| Highlander Partners, L.P. | 122,980 | $4,204,686 | 2.80% |